About Spore Biotechnologies
Spore Biotechnologies is a Healthcare company based in Paris (France) founded in 2022 by Amine Raji and Maxime Mistretta. Microbial detection technology is developed for life science industries. Spore Biotechnologies has raised $31.61 million across 3 funding rounds from investors including STATION F, Singular and Point72 Ventures. Its chief executive, as recorded, is Amine Raji. Its website spore.bio draws about 12 thousand monthly visits. Spore Biotechnologies offers products and services including AI Microbiology Technology. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing.
Company details
Spore Biotechnologies was founded in 2022 and is based in Paris, France. Bacterial and microbial risks are detected through technologies tailored for food and beverage, cosmetics, and pharmaceuticals sectors within life sciences. Operations center on creating detection solutions to support manufacturers in risk assessment and compliance. The company is led by co-founders Amine Raji as CEO and Maxime Mistretta.
- Total Equity Funding$31.61M (USD)
in 3 rounds
- InvestorsSTATION F
& 12 more
Products & Services of Spore Biotechnologies
Spore Biotechnologies offers a comprehensive portfolio of products and services, including AI Microbiology Technology.
AI tool for rapid microbiology analysis and diagnostics
Funding Insights of Spore Biotechnologies
Spore Biotechnologies has successfully raised a total of $31.61M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.61M
- Total Rounds 3
- First Round $8.61M
(Dec 2023)
- Investors Count 13
All 3 funding rounds of Spore Biotechnologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | Grant | – | – | ||
| Feb 2025 | $23M | Series A | – | Singular | |
| Dec 2023 | $8.61M | Seed | – | LocalGlobe |
13 investors in total: 11 institutional and 2 angel.
Investors in Spore Biotechnologies
Spore Biotechnologies has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include STATION F, Singular and Point72 Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are made in European startups. | singular.vc | |||
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies | p72.vc | New York, United States | ||
Startups are accelerated and incubated via structured programs. | 2017 | stationf.co | Paris, France | |
Early-stage venture capital is provided to immigrant entrepreneurs in Europe. | 2023 | nolabel.ventures | London, United Kingdom | |
Investments are made in beauty, technology, and luxury hospitality sectors. | 2018 | famillec-participations.com | Paris, France | |
Venture capital firm focused on seed-stage investments | localglobe.vc | London, United Kingdom | ||
Early stage investments are made in European tech founders. | 1stkind.vc | Neuilly, France | ||
Venture capital funding is offered to tech entrepreneurs. | emtechvc.com | |||
Awareness is raised to end human sex trafficking in Chattanooga. | famillecventure.com | Chattanooga, United States | ||
Limited information is provided about Better Angle's activities. | better-angle.com |
Investor details for Spore Biotechnologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Spore Biotechnologies
5 people are tracked at Spore Biotechnologies (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Amine Raji | Co-Founder & CEO | Leadership |
Maxime Mistretta | Co-Founder | Leadership |
Mohamed Tazi | Co-founder & COO | Leadership |
Ariane Bonnel | Full-stack Software Engineer | Team |
Aloïs de la Comble | Lead Data Scientist | Team |
Complete people profiles for Spore Biotechnologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Spore Biotechnologies
3 dated milestones of Spore Biotechnologies across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Spore Biotechnologies is founded.
- Funding First funding round of $8.6M.
- Funding Latest funding round, Grant,.
Web traffic of Spore Biotechnologies
The website of Spore Biotechnologies (spore.bio) receives about 11.5K visits a month.
- Monthly visits11.5K
▲ 69.6% vs previous month
Websites whose visitors overlap most with Spore Biotechnologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
laminute.info | laminute.info | 100% | #1,120,892 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spore Biotechnologies
Complete news archive for Spore Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spore Biotechnologies
Spore Biotechnologies was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Spore Biotechnologies is headquartered in Paris, France.
Amine Raji is the CEO of Spore Biotechnologies, as recorded in our data. They have also founded this company.
Spore Biotechnologies is a funded company, having raised a total of $31.61M across 3 funding rounds to date. The company's 1st funding round was a Seed of $8.61M, raised on Dec 2023.
Spore Biotechnologies was founded in 2022 and is based in Paris, France. Bacterial and microbial risks are detected through technologies tailored for food and beverage, cosmetics, and pharmaceuticals sectors within life sciences. Operations center on creating detection solutions to support manufacturers in risk assessment and compliance. The company is led by co-founders Amine Raji as CEO and Maxime Mistretta.
Spore Biotechnologies offers AI Microbiology Technology.
Spore Biotechnologies has 13 investors. Key investors include STATION F, Singular, Point72 Ventures, No Label Ventures, and Famille C Participations.